Abstract: Monoclonal receptors raised to immunogenic polypeptides whose amino acid residue sequences correspond to sequences of oncoprotein ligands are disclosed, as are methods for the production of those receptors and products and methods that utilize them. The monoclonal receptors bind both to the oncoprotein ligand and to the immunogenic polypeptide to which the receptors were raised.